Skip to main content

Month: June 2020

Kommuniké från Bilias årsstämma 2020

Bilia AB:s årsstämma hölls måndagen den 22 juni 2020, i Stockholm.Fastställande av balans- och resultaträkningÅrsstämman fastställde balans- och resultaträkningarna för moderbolaget och koncernen för verksamhetsåret 2019.ResultatdispositionAktieägarna beslutade i enlighet med styrelsens förslag att ingen utdelning lämnas för räkenskapsåret 2019 och att tillgängliga medel balanseras i ny räkning.Antalet styrelseledamöter och val av styrelseStämman beslutade att styrelsen skulle bestå av nio ledamöter, utan suppleanter. Till ordinarie ledamöter i styrelsen omvaldes Ingrid Jonasson Blank, Gunnar Blomkvist, Anna Engebretsen, Eva Eriksson, Mats Holgerson, Nicklas Paulson, Jan Pettersson, Mats Qviberg och Jon Risfelt. Mats Qviberg omvaldes till styrelsens ordförande med Jan Pettersson som vice ordförande.StyrelsearvodeÅrsstämman fastställde...

Continue reading

Recruiter.com Appoints Evan Sohn as CEO

HOUSTON, June 22, 2020 (GLOBE NEWSWIRE) — Recruiter.com Group, Inc. (OTCQB:RCRT), a leading hiring platform for the world’s largest network of recruiters (“Recruiter.com” or the “Company”), today announced the appointment of Evan Sohn as Chief Executive Officer. Mr. Sohn previously served as the Company’s Executive Chairman and will continue to serve as Chairman of the Board of Directors. Miles Jennings, the Company’s former CEO and Founder, will continue on as COO.“Evan is a veteran entrepreneur and visionary executive with experience driving category-leading product innovation and building deep client relationships,” said Miles Jennings. “I am confident that Evan will continue to help Recruiter.com move forward as a rapidly growing and disruptive recruiting technology company.”“During my time...

Continue reading

Marrone Bio Innovations Regains Compliance with Nasdaq Minimum Bid Price Requirement

DAVIS, Calif., June 22, 2020 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that it received notice from The Nasdaq Stock Market, LLC (“Nasdaq”) on June 19, 2020 indicating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market.“We are pleased to announce to our shareholders that the Company has regained full compliance with Nasdaq’s continued listing requirements,” said Pam Marrone, Founder and Chief Executive Officer of Marrone Bio Innovations. “With this matter now resolved, our officers and directors will continue to remain focused on driving growth and creating sustainable shareholder...

Continue reading

Saratoga Investment Corp. to Report Fiscal First Quarter 2021 Financial Results and Hold Conference Call

NEW YORK, June 22, 2020 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial results for the fiscal quarter ended May 31, 2020, on July 8, 2020, after market close. A conference call to discuss the financial results will be held on July 9, 2020. Details for the conference call are provided below.Information:  Saratoga Investment Corp.’s Form 10-Q for the fiscal quarter ended May 31, 2020, will be filed on July 8, 2020, with the Securities and Exchange Commission.About Saratoga Investment Corp.Saratoga Investment is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change...

Continue reading

Manitou Gold Provides Update on Exploration Activities at its 100% Owned Goudreau Project in Northern Ontario

SUDBURY, Ontario, June 22, 2020 (GLOBE NEWSWIRE) — Manitou Gold Inc. (TSX-V: MTU) (the “Company” or “Manitou”) is pleased to provide an update of its exploration activities on its 340 square km Goudreau Project located north of Wawa, Ontario. The ongoing exploration program includes drilling focused on the exploration and expansion of gold mineralization on the Rockstar vein, which continues to show down-plunge continuity. A property-wide airborne geophysical survey was recently completed, along with approximately nine square kilometers of detailed ground geophysics covering the central part of the Baltimore Deformation Zone (“BDZ”) on the Stover grid. An exploration program consisting of geological mapping and prospecting, soil geochemistry and mechanized stripping at the Stover grid was initiated on June 16. The program is designed...

Continue reading

Ayala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update

– Completed upsized initial public offering raising a total of $59.1 million in gross proceeds– Current cash balance expected to fund operations into second half of 2022– Fast Track Designation granted for lead candidate, AL101 for the treatment of R/M ACC; additional Phase 2 data expected in 2H20– Dosing commenced in the R/M ACC study in the 6mg cohort– IND accepted by FDA for Phase 2 study in AL101 for the treatment of TNBC; study on track to initiate in second half of 2020REHOVOT, Israel and WILMINGTON, Del., June 22, 2020 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today reported financial results...

Continue reading

Contango Announces First Quarter 2020 Financial Results

HOUSTON, June 22, 2020 (GLOBE NEWSWIRE) — Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) announced today its financial results for the first quarter ended March 31, 2020. First Quarter 2020 HighlightsProduction of 1,720 Mboe for the quarter, or 18.9 Mboe per day, a 216% increase from the 6.0 Mboe per day in the prior year quarter, primarily due to additional production from the properties acquired from White Star Petroleum, LLC and certain affiliates (collectively, “White Star”) and Will Energy Corporation (“Will Energy”) in the fourth quarter of 2019.Initiated flowback from the State Spearhead #1H well in Pecos County, Texas, in the Southern Delaware Basin, in January 2020.Net loss of $105.3 million (including $145.9 million in pre-tax impairments), compared to a net loss of $8.6 million in the...

Continue reading

Corbus Pharmaceuticals Reports Last Subject Visit in Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis

Topline data on schedule for Q3 2020Reduction in pulmonary exacerbations (PEx) as primary endpointStudy enrolled 426 participants regardless of CFTR mutation or background CFTR-targeting therapiesTreatment of inflammation to reduce PEx remains a key unmet need in CFStudy is funded in part by a Development Award for up to $25 Million from the Cystic Fibrosis FoundationNorwood, MA, June 22, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that the last subject completed their final visit in the Company’s Phase 2b JBT101-CF-002 trial of lenabasum for the treatment of cystic fibrosis. Topline results from the study are on track to readout in the...

Continue reading

Ceapro Announces Results of 2020 Shareholders’ Meeting

EDMONTON, Alberta, June 22, 2020 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that all proposed Directors were elected to serve for a one-year term at its Annual General and Special Meeting of Shareholders held on June 19, 2020 as per the following results:All other matters at the Shareholders’ meeting, namely the appointment of auditors and the re-approval and ratification of the Company’s Stock Option Plan, as proposed in the Company’s information circular dated April 30, 2020, were also approved by shareholders.About Ceapro Inc.Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary...

Continue reading

Kirkland Lake Gold Announces Management Appointments

TORONTO, June 22, 2020 (GLOBE NEWSWIRE) — Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL) (ASX:KLA) today announced a number of management appointments intended to enhance the depth and effectiveness of the Company’s leadership team as it moves forward as a leading senior gold producer with industry-leading financial performance and strength. All appointments listed below are effective immediately.Among the appointments:Greg Gibson joins the Company as Special Advisor to the CEO, Business Process Improvement;Natasha Vaz is promoted to Senior Vice President, Technical Services and Innovation from her current position of Vice-President, Technical Services;Jennifer Wagner is promoted to Senior Vice President, Corporate Affairs, Legal Counsel and Corporate Secretary from Vice President, Legal;Mark...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.